CASSY WILLIAMS: Open Payments
NPI 1356617815 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 57 payments from 9 companies in 2025. Trend: 2023 $17 · 2024 $432 · 2025 $1,022
Food & beverage: $1,022
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $214 |
| ABBVIE INC. | 16 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $151 |
| Indivior Inc. | 5 | $118 |
| Alkermes, Inc. | 5 | $102 |
| Braeburn Inc. | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 3 | $88 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Exact Sciences Corporation | 1 | $20 |
Products named: CAPLYTA, MAVYRET, SUBLOCADE, BRIXADI, REXULTI, VRAYLAR, LYBALVI, Auvelity.
Industry payments across MA — which companies pay providers there.
